Researcher Profile

Researcher Profile

Thomas Riley III, MD, MS

Thomas Riley III, MD, MS

Professor, Department of Medicine
Division of Gastroenterology and Hepatology
Disease Teams:
Liver, Pancreas and Foregut Cancer
trr5@psu.edu

Research Interests

  • Liver
  • Therapeutics
  • Liver Diseases
  • Chronic Disease
  • Liver Transplantation
  • Antiviral Agents
  • Hepatitis C
  • Chronic Hepatitis C
  • Fibrosis
  • Hepacivirus
  • Biopsy
  • Medicare

Recent Publications

2021

Tran, L, Feldman, R, Riley, T & Jung, J 2021, 'Association of the Extension for Community Healthcare Outcomes Project with Use of Direct-Acting Antiviral Treatment among US Adults with Hepatitis C', JAMA network open, vol. 4, no. 7, e2115523. https://doi.org/10.1001/jamanetworkopen.2021.15523
Du, P, Wang, X, Kong, L, Riley, T & Jung, J 2021, 'Changing Urban–Rural Disparities in the Utilization of Direct-Acting Antiviral Agents for Hepatitis C in U.S. Medicare Patients, 2014–2017', American Journal of Preventive Medicine, vol. 60, no. 2, pp. 285-293. https://doi.org/10.1016/j.amepre.2020.08.031
Roy, J, Kang, M, Stern, B, Riley, T & Schreibman, I 2021, 'Lactulose-induced pneumatosis intestinalis following colonoscopy: a case report', Clinical Journal of Gastroenterology, vol. 14, no. 4, pp. 1152-1156. https://doi.org/10.1007/s12328-021-01392-9
Du, P, Jung, J, Kalidindi, Y, Farrow, K, Riley, T & Whitener, C 2021, 'Low utilization of direct-acting antiviral agents in a large national cohort of HIV and HCV coinfected medicare patients in the United States: Implications for HCV elimination', Journal of Public Health Management and Practice. https://doi.org/10.1097/PHH.0000000000001147
Noverati, N, Federici, E & Riley, TR 2021, 'Post-transfusion hemoglobin response in patients with cirrhosis: Can we expect a 1 g/dL rise per unit transfused?', Transfusion, vol. 61, no. 3, pp. 708-712. https://doi.org/10.1111/trf.16238
Kadry, Z, Stine, J, Dohi, T, Jain, A, Robyak, KL, Kwon, O, Hamilton, CJ, Janicki, P, Riley III, T, Butt, F, Krok, K, Schreibman, I, Bezinover, D, Ghahramani, N, Campos, S & Hollenbeak, CS 2021, 'Renal Protective Effect of Everolimus in Liver Transplantation: A Prospective Randomized Open-Label Trial', Transplantation Direct. https://doi.org/10.1097/TXD.0000000000001159

2020

Jung, J, Feldman, R, Kalidindi, Y & Riley, T 2020, 'Association of Direct-Acting Antiviral Therapy for Hepatitis C With After-Treatment Costs Among Medicare Beneficiaries', JAMA network open, vol. 3, no. 6, pp. e208081. https://doi.org/10.1001/jamanetworkopen.2020.8081
Kalidindi, Y, Jung, J, Feldman, R & Riley, T 2020, 'Association of Direct-Acting Antiviral Treatment With Mortality Among Medicare Beneficiaries With Hepatitis C', JAMA network open, vol. 3, no. 7, pp. e2011055. https://doi.org/10.1001/jamanetworkopen.2020.11055
Jung, J, Du, P, Feldman, R & Riley, T 2020, 'Discontinuation of new hepatitis C drugs among Medicare patients', American Journal of Managed Care, vol. 26, no. 2, pp. 84-88. https://doi.org/10.37765/ajmc.2020.42397
Jain, A, Riley, TR, Krok, KL, Schreibman, I, Karamchandani, DM, Liao, X, Tian, Y, Dohi, T & Kadry, Z 2020, 'Incidence of post-liver transplant hepatic dysfunction after sustained virologic response following direct-acting anti-hepatitis c therapy', Experimental and Clinical Transplantation, vol. 18, no. 3, pp. 345-352. https://doi.org/10.6002/ect.2018.0127

2019

Loloi, J, Patel, A, McDevitt, P, Bruno, MA & Riley, T 2019, 'How Strongly Do Physical Examination Estimates and Ultrasonographic Measurements of Liver Size Correlate? A Prospective Study', American Journal of Medicine, vol. 132, no. 1, pp. 103-108. https://doi.org/10.1016/j.amjmed.2018.09.012
Jain, A, Miller, D, Schreibman, I, Riley, TR, Krok, KL, Dohi, T, Sharma, R & Kadry, Z 2019, 'Is there increased risk of hepatocellular carcinoma recurrence in liver transplant patients with direct-acting antiviral therapy?', Hepatology International, vol. 13, no. 2, pp. 190-198. https://doi.org/10.1007/s12072-019-09930-x
Jung, J, Du, P, Feldman, R, Kong, L & Riley, T 2019, 'Racial/ethnic and socioeconomic disparities in use of direct-acting antivirals among Medicare beneficiaries with chronic hepatitis C, 2014-2016', Journal of Managed Care and Specialty Pharmacy, vol. 25, no. 11, pp. 1236-1242. https://doi.org/10.18553/jmcp.2019.25.11.1236

2018

Shike, H, Kadry, Z, Imamura-Kawasawa, Y, Greene, W, Riley, T, Nathan, HM, Hasz, RD & Jain, A 2018, 'Hepatitis C virus (HCV) RNA level in plasma and kidney tissue in HCV antibody-positive donors: Quantitative comparison', Clinical Transplantation, vol. 32, no. 9, e13358. https://doi.org/10.1111/ctr.13358
Bezinover, D, Deacutis, MF, Dalal, P, Moore, RP, Stine, J, Wang, M, Reeder, E, Hollenbeak, CS, Saner, FH, Riley III, T & Janicki, P 2019, 'Perioperative thrombotic complications associated with pediatric liver transplantation: a UNOS database evaluation', HPB, vol. 21, no. 3, pp. 370-378. https://doi.org/10.1016/j.hpb.2018.08.014

2017

Kasmari, AJ, Welch, A, Liu, G, Leslie, D, McGarrity, T & Riley, T 2017, 'Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome', American Journal of Medicine, vol. 130, no. 6, pp. 746.e1-746.e7. https://doi.org/10.1016/j.amjmed.2016.12.029

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)